Zynerba Pharmaceuticals ZYNE
$ 1.3
0.0%
Quarterly report 2023-Q2
added 08-14-2023
Country |
USA |
IPO year |
2015 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Armando Anido |
Employees in the company |
28 |
Shares |
42.7 M |
Market Cap[1] |
$ 55.5 M |
EBITDA (LTM) |
$ -36.6 M |
P/E (LTM) |
-1.57 |
P/S (LTM) |
- |
EPS (LTM) |
-0.86 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.